NEW Dividend Portfolio Tracker (DRIPTracker) is Now Live!
Track your stocks, dividends, monitor DRIP shares, and project your passive income.
Start Free »

Eli Lilly and Company LLY | NYSE

$1,148.20 $0.00 | 0.00%

Next Earnings: Sep 04, 2026

Company Overview:

Market Cap: $0
Trailing PE: 0x
FWD PE *: 28.1x
Payout Ratio (TTM): 21.7%
52-Week Range: $712.05 - $1,292.65

* Forward PE is based on street estimates.

10 Year LLY Performance Metrics:

Total Return (with DRIP): 1,613% (32.86% CAGR)
Total Return (no DRIP): 1,410% (31.19% CAGR)
Share Price: 1,394% (31.05% CAGR)
Yield on Cost (with DRIP): 10.33%
Total Invested: $10,000
Total Value (with DRIP): $171,326
Total Return $ (with DRIP): $161,326
Dividend Increase: 239.2% (13.34% CAGR)
Dividend Yield (FWD): 0.60% ($6.92)
LLY 10-yr Total Return ($10K invested)
1Y 2Y 5Y 10Y All

LLY Share Price chart

Share Price
LLY Price CAGR:1Y: 54.55%2Y: 10.15%5Y: 34.64%10Y: 31.05%
LLY Dividend Charts
LLY - Dividends
LLY Dividend CAGR:1Y: 15.33%2Y: 15.36%5Y: 15.27%10Y: 12.99%
LLY - Dividend Payout Ratio
LLY - Dividend to Free Cash Flow Ratio

Unlock All Reports & Research Dividend Stocks.

Save 25% with annual plan (3 Months Free)
Pro
$171 ($14.25/mo) $128.25/yr ($10.69/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Stock Fundamentals
  • DCF valuation modeling
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
Start Free Trial
You save $99.75 (44%)
Most Popular
Premium
$288 ($24/mo) $216/yr ($18/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • Stocks Dashboard
Start Free Trial
You save $168 (44%)
Ultra
$576 ($48/mo) $432/yr ($36/mo)
7-day free trial
  • Everything in Premium
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Start Free Trial
You save $336 (44%)

LLY Earnings, Revenue, Cash & Debt, Shares Outstanding:

LLY - Revenue
LLY Revenue CAGR:1Y: 47.67%2Y: 42.57%5Y: 27.80%10Y: 15.57%
LLY - Earnings Per Share (EPS)
LLY EPS CAGR:1Y: 26.23%2Y: 55.59%5Y: 39.00%10Y: 27.31%
LLY - Net Income
LLY Net Income CAGR:1Y: 25.34%2Y: 54.64%5Y: 38.54%10Y: 25.23%
LLY - EBITDA
LLY EBITDA CAGR:1Y: 23.23%2Y: 49.90%5Y: 37.82%10Y: 24.43%
LLY - Free Cash Flow
LLY Free Cash Flow CAGR:1Y: 504.60%2Y: 1,006.12%5Y: 44.20%10Y: 20.96%
LLY - Free Cash Flow / Share
LLY Free Cash Flow / Share CAGR:1Y: 508.32%2Y: 1,011.38%5Y: 44.68%10Y: 23.04%
LLY - Operating Income
LLY Operating Income CAGR:1Y: 25.99%2Y: 42.55%5Y: 44.43%10Y: 25.54%
LLY - Gross Profit
LLY Gross Profit CAGR:1Y: 50.31%2Y: 46.89%5Y: 32.71%10Y: 17.47%
LLY - Shares Outstanding
LLY Shares Outstanding CAGR:1Y: -0.68%2Y: -0.58%5Y: -0.37%10Y: -1.69%
LLY - Share Buybacks
LLY Share Buybacks CAGR:1Y: 131.29%2Y: 0.00%5Y: 26.21%10Y: 0.00%
LLY - Stock-Based Comp
LLY Stock-Based Comp CAGR:1Y: 8.59%2Y: -2.42%5Y: 16.94%10Y: 11.95%
LLY - Expenses
LLY Expenses CAGR:1Y: 62.59%2Y: 44.60%5Y: 40.73%10Y: 28.16%
LLY - Revenue vs Net Income
LLY - EPS vs FCF / Share
LLY - EPS vs PE Ratio
LLY - FCF vs FCF / Share
LLY - FCF vs Stock Based Comp
LLY - Cash & Debt
LLY - Revenue by Segment
LLY Revenue CAGR:1Y: 47.67%2Y: 42.57%5Y: 27.80%10Y: 15.57%
LLY - Revenue by Region
LLY Revenue CAGR:1Y: 47.67%2Y: 42.57%5Y: 27.80%10Y: 15.57%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

LLY - REVENUE: Actual + Estimates
LLY Actual Revenue CAGR:1Y: 47.67%2Y: 42.57%5Y: 27.80%10Y: 15.57%
LLY - EPS: Actual + Estimates
LLY Actual EPS CAGR:1Y: 26.23%2Y: 55.59%5Y: 39.00%10Y: 27.31%
LLY - NET INCOME: Actual + Estimates
LLY Actual Net Income CAGR:1Y: 25.34%2Y: 54.64%5Y: 38.54%10Y: 25.23%
LLY - EBITDA: Actual + Estimates
LLY Actual EBITDA CAGR:1Y: 23.23%2Y: 49.90%5Y: 37.82%10Y: 24.43%

Ratios, Profit Margins & Return on Capital:

LLY - Net Profit Margin
LLY Net Profit Margin CAGR:1Y: -15.12%2Y: 8.46%5Y: 8.40%10Y: 8.36%
LLY - Gross Profit Margin
LLY Gross Profit Margin CAGR:1Y: 1.79%2Y: 3.04%5Y: 3.85%10Y: 1.64%
LLY - Price to Earnings
LLY - Price To Sales Ratio
LLY - Return on Capital Employed
LLY - Return on Invested Capital

Compare stocks side-by-side
 

LLY Dividends Info:

Annual Dividend: $6.92
Forward Yield: 0.6%
Ex-Dividend Date: 2026-08-14
Lifetime Dividends / Share: $75.94

LLY Dividend History: Dates, Payments & Yield list

Below is a schedule of all LLY dividend payments, ex-dates, share price on the day of the payment as well as the annualized yield & forward yield

Ex-Date Payment Date Amount Yield Forward Yield Price on Ex-Date
08/14/202609/10/2026$1.7300.59%0.58%$1,183.16
05/15/202606/10/2026$1.7300.69%0.61%$1,136.37
02/13/202603/10/2026$1.7300.67%0.69%$1,001.35
11/14/202512/10/2025$1.5000.59%0.6%$993.64
08/15/202509/10/2025$1.5000.86%0.8%$754.62
05/16/202506/10/2025$1.5000.79%0.74%$807.19
02/14/202503/10/2025$1.5000.71%0.72%$829.76
11/15/202412/10/2024$1.3000.7%0.65%$799.58
08/15/202409/10/2024$1.3000.56%0.58%$901.25
05/15/202406/10/2024$1.3000.66%0.6%$865.00
02/14/202403/08/2024$1.3000.69%0.68%$762.14
11/14/202312/08/2023$1.1300.74%0.76%$598.05
08/14/202309/08/2023$1.1300.84%0.77%$586.46
05/12/202306/09/2023$1.1301.04%1.01%$446.04
02/14/202303/10/2023$1.1301.3%1.43%$315.02
11/14/202212/09/2022$0.9801.1%1.09%$360.99
08/12/202209/09/2022$0.9801.27%1.23%$317.70
05/13/202206/10/2022$0.9801.34%1.32%$297.01
02/14/202203/10/2022$0.9801.67%1.47%$266.02
11/12/202112/10/2021$0.8501.31%1.39%$244.14
08/12/202109/10/2021$0.8501.29%1.42%$239.50
05/13/202106/10/2021$0.8501.74%1.46%$233.54
02/11/202103/10/2021$0.8501.68%1.65%$205.45
11/12/202012/10/2020$0.7402.1%1.84%$161.00
08/13/202009/10/2020$0.7401.97%2.02%$146.22
05/14/202006/10/2020$0.7401.87%1.96%$151.00
02/13/202003/10/2020$0.7402.09%2.1%$141.19
11/14/201912/10/2019$0.6452.32%2.14%$120.65
08/14/201909/10/2019$0.6452.34%2.32%$111.10
05/16/201906/10/2019$0.6452.21%2.26%$113.93
02/14/201903/08/2019$0.6452.14%2.04%$126.70
11/14/201812/10/2018$0.5632.05%1.97%$114.09
08/14/201809/10/2018$0.5632.2%2.11%$106.42
05/16/201806/08/2018$0.5632.77%2.61%$86.08
02/14/201803/09/2018$0.5632.92%2.83%$79.61
11/14/201712/08/2017$0.5202.52%2.41%$86.45
08/11/201709/08/2017$0.5202.56%2.51%$82.92
05/11/201706/09/2017$0.5202.59%2.57%$81.04
02/13/201703/10/2017$0.5202.67%2.47%$84.36
11/10/201612/09/2016$0.5102.6%3.01%$67.85
08/11/201609/09/2016$0.5102.53%2.61%$78.24
05/11/201606/10/2016$0.5102.67%2.76%$73.95
02/10/201603/10/2016$0.5102.79%2.79%$73.02
11/10/201512/10/2015$0.5002.5%2.36%$84.91
08/12/201509/10/2015$0.5002.4%2.47%$80.84
05/14/201506/10/2015$0.5002.74%2.4%$83.18
02/11/201503/10/2015$0.5002.86%2.91%$68.78
11/12/201412/10/2014$0.4902.91%2.76%$71.05
08/13/201409/10/2014$0.4903.23%3.03%$64.78
05/13/201406/10/2014$0.4903.26%3.28%$59.75
02/12/201403/10/2014$0.4903.68%3.33%$58.90
11/13/201312/10/2013$0.4903.88%3.88%$50.49
08/13/201309/10/2013$0.4903.57%3.71%$52.87
05/14/201306/10/2013$0.4903.51%3.72%$52.64
02/13/201303/08/2013$0.4903.67%3.55%$55.16
11/13/201212/10/2012$0.4904.16%3.91%$50.12
08/13/201209/10/2012$0.4904.58%4.21%$46.52
05/11/201206/08/2012$0.4904.75%4.72%$41.53
02/13/201203/09/2012$0.4905.05%4.95%$39.56
11/10/201112/09/2011$0.4905.26%4.99%$39.27
08/11/201109/09/2011$0.4905.55%5.42%$36.13
05/11/201106/10/2011$0.4905.12%5.29%$37.05
02/11/201103/10/2011$0.4905.68%5.64%$34.77
11/10/201012/10/2010$0.4905.6%5.6%$34.98
08/11/201009/10/2010$0.4905.34%5.53%$35.43
05/12/201006/10/2010$0.4905.64%5.86%$33.46
02/10/201003/10/2010$0.4905.74%5.55%$35.34
11/10/200912/10/2009$0.4905.56%5.6%$35.02
08/12/200909/10/2009$0.4905.95%5.97%$32.82
05/13/200906/10/2009$0.4905.58%5.78%$33.91
02/11/200903/10/2009$0.4905.34%6.59%$29.72
11/12/200812/10/2008$0.4705.88%5.37%$35.01
08/13/200809/10/2008$0.4703.89%4.02%$46.73
05/13/200806/10/2008$0.4703.95%3.92%$47.94
02/13/200803/10/2008$0.4703.73%3.8%$49.42
11/13/200712/10/2007$0.4253.23%3.1%$54.78
08/13/200709/10/2007$0.4252.99%3.03%$56.14
05/11/200706/08/2007$0.4252.91%2.98%$57.02
02/13/200703/09/2007$0.4253.13%3.23%$52.59
11/13/200612/08/2006$0.4002.96%2.96%$54.00
08/11/200609/08/2006$0.4002.94%2.9%$55.26
05/11/200606/09/2006$0.4003.13%3.09%$51.74
02/13/200603/10/2006$0.4002.89%2.79%$57.25
11/10/200512/09/2005$0.3802.96%2.85%$53.41
08/11/200509/09/2005$0.3802.83%2.68%$56.72
05/11/200506/10/2005$0.3802.59%2.67%$56.99
02/11/200503/10/2005$0.3802.74%2.74%$55.56
11/10/200412/10/2004$0.3552.55%2.58%$55.04
08/11/200409/10/2004$0.3552.27%2.16%$65.85
05/12/200406/10/2004$0.3551.93%1.93%$73.64
02/11/200403/10/2004$0.3551.9%2.01%$70.49
11/12/200312/10/2003$0.3352.02%1.9%$70.40
08/13/200309/10/2003$0.3352.15%2.16%$62.03
05/13/200306/10/2003$0.3352.1%2.22%$60.23
02/12/200303/10/2003$0.3352.28%2.39%$56.00
11/13/200212/10/2002$0.3102.06%1.88%$66.10
08/13/200209/10/2002$0.3102.21%2.14%$57.81
05/13/200206/10/2002$0.3101.92%2.02%$61.31
02/13/200203/08/2002$0.3101.63%1.59%$78.20
11/13/200112/10/2001$0.2801.42%1.37%$81.54
08/13/200109/10/2001$0.2801.43%1.45%$77.20
05/11/200106/11/2001$0.2801.33%1.29%$87.00
02/13/200103/09/2001$0.2801.4%1.42%$79.00
11/13/200012/11/2000$0.2601.21%1.12%$92.88
08/11/200009/11/2000$0.2601.35%1.48%$70.25
05/11/200006/09/2000$0.2601.39%1.37%$76.19
02/11/200003/10/2000$0.2601.69%1.7%$61.19
11/10/199912/10/1999$0.2301.21%1.4%$65.88
08/11/199909/10/1999$0.2301.5%1.27%$72.38
05/12/199906/10/1999$0.2301.2%1.3%$70.69
02/10/199903/10/1999$0.2301.05%1%$91.81
11/10/199812/10/1998$0.2000.93%0.92%$86.81
08/12/199809/10/1998$0.2001.17%1.1%$72.81
05/13/199806/10/1998$0.2001.17%1.26%$63.38
02/11/199803/10/1998$0.2001.21%1.2%$66.44
11/12/199712/10/1997$0.2001.27%1.26%$63.31
08/13/199709/10/1997$0.1801.38%1.37%$52.59
05/13/199706/10/1997$0.1801.55%1.44%$50.00
02/12/199703/10/1997$0.1801.59%1.57%$45.75
11/13/199612/10/1996$0.1711.81%1.83%$37.44
08/13/199609/10/1996$0.1712.32%2.31%$29.63
05/13/199606/10/1996$0.1712.45%2.06%$33.31
02/13/199603/11/1996$0.1712.14%2.14%$32.00
11/13/199512/11/1995$0.1712.84%2.7%$25.41
08/11/199509/11/1995$0.1613.4%3.1%$20.81
05/09/199506/12/1995$0.1613.52%3.39%$19.00
02/09/199503/10/1995$0.1613.93%3.79%$17.03
11/08/199412/12/1994$0.1563.96%3.99%$15.66
08/09/199409/12/1994$0.1565.13%4.44%$14.09
05/09/199406/10/1994$0.1564.71%4.38%$14.28
02/09/199403/10/1994$0.1564.33%4.8%$13.03
11/08/199312/10/1993$0.1514.34%4.23%$14.31
08/09/199309/10/1993$0.1515.46%5.02%$12.06
05/10/199306/10/1993$0.1514.77%4.89%$12.38
02/09/199303/10/1993$0.1514.45%4.55%$13.31
11/06/199212/10/1992$0.1383.59%3.37%$16.31
08/10/199209/10/1992$0.1383.15%3.29%$16.72
05/11/199206/10/1992$0.1383.27%3.4%$16.16
02/10/199203/10/1992$0.1382.78%3.05%$18.06
11/08/199112/10/1991$0.1252.63%2.7%$18.53
08/09/199109/10/1991$0.1252.52%2.49%$20.06
05/09/199106/10/1991$0.1252.6%2.62%$19.09
02/07/199103/11/1991$0.1252.71%2.4%$20.81
11/08/199012/10/1990$0.1032.39%2.15%$19.06
08/09/199009/10/1990$0.1032.1%2.18%$18.81
05/09/199006/11/1990$0.1032.38%2.14%$19.19
02/09/199003/12/1990$0.1032.61%2.6%$15.75
11/09/198912/11/1989$0.0842.11%2.09%$16.16
08/09/198909/11/1989$0.0842.2%2.23%$15.09
05/09/198906/12/1989$0.0842.56%2.37%$14.19
02/09/198903/10/1989$0.0842.85%2.73%$12.38
11/08/198812/12/1988$0.0722.64%2.62%$10.98
08/09/198809/12/1988$0.0722.76%2.66%$10.81
05/09/198806/10/1988$0.0722.98%2.73%$10.53
02/09/198803/10/1988$0.0723.15%2.96%$9.70
11/06/198712/10/1987$0.0632.65%2.92%$8.56
08/10/198709/10/1987$0.0632.02%2.12%$11.78
05/11/198706/10/1987$0.0632.31%2.13%$11.75
02/09/198703/10/1987$0.0632.35%2.04%$12.25
11/07/198611/12/1986$0.0562.41%2.37%$9.50
08/11/198608/13/1986$0.0562.37%2.26%$9.94
05/09/198605/14/1986$0.0562.55%2.63%$8.56
02/10/198602/12/1986$0.0563.22%3.21%$7.02
11/08/198511/13/1985$0.0503.36%3.22%$6.22
08/09/198508/14/1985$0.0503.85%3.77%$5.31
05/09/198505/13/1985$0.0504.07%4.07%$4.91
02/08/198502/13/1985$0.0504.4%4.36%$4.59
11/08/198411/12/1984$0.0505.09%5.1%$3.92
08/09/198408/13/1984$0.0454.97%5.05%$3.59
05/09/198405/11/1984$0.0454.66%4.64%$3.91
02/08/198402/10/1984$0.0454.72%4.67%$3.88
11/07/198311/09/1983$0.0450%4.8%$3.78
08/09/198308/11/1983$0.0450%4.8%$3.78
05/09/198305/11/1983$0.0410%4.3%$3.78
02/09/198302/11/1983$0.0410%4.3%$3.78
11/05/198211/10/1982$0.0410%4.3%$3.78
08/09/198208/11/1982$0.0410%4.3%$3.78
05/10/198205/12/1982$0.0410%4.3%$3.78
02/08/198202/10/1982$0.0410%4.3%$3.78
11/06/198111/11/1981$0.0360%3.8%$3.78
08/10/198108/12/1981$0.0360%3.8%$3.78
05/11/198105/13/1981$0.0360%3.8%$3.78
02/05/198102/09/1981$0.0360%3.8%$3.78
11/07/198011/12/1980$0.0360%3.8%$3.78
08/11/198008/13/1980$0.0360%3.8%$3.78
05/12/198005/14/1980$0.0330%3.47%$3.78
02/08/198002/13/1980$0.0330%3.47%$3.78
11/02/197911/07/1979$0.0330%3.47%$3.78
08/06/197908/08/1979$0.0330%3.47%$3.78
05/07/197905/09/1979$0.0280%2.98%$3.78
02/05/197902/07/1979$0.0280%2.98%$3.78
11/03/197811/08/1978$0.0280%2.98%$3.78
08/07/197808/09/1978$0.0250%2.65%$3.78
05/08/197805/10/1978$0.0250%2.65%$3.78
02/06/197802/08/1978$0.0250%2.65%$3.78
11/03/197711/07/1977$0.0220%2.35%$3.78
08/08/197708/10/1977$0.0220%2.35%$3.78
05/09/197705/11/1977$0.0220%2.35%$3.78
02/04/197702/09/1977$0.0220%2.35%$3.78
11/05/197611/10/1976$0.0200%2.15%$3.78
08/09/197608/11/1976$0.0200%2.15%$3.78
05/10/197605/12/1976$0.0190%1.98%$3.78
02/06/197602/11/1976$0.0190%1.98%$3.78
11/07/197511/12/1975$0.0170%1.82%$3.78
08/11/197508/13/1975$0.0170%1.82%$3.78
05/12/197505/14/1975$0.0170%1.82%$3.78
02/07/197502/12/1975$0.0170%1.82%$3.78
11/08/197411/13/1974$0.0160%1.65%$3.78
08/12/197408/14/1974$0.0160%1.65%$3.78
05/13/197405/15/1974$0.0150%1.55%$3.78
02/08/197402/13/1974$0.0150%1.55%$3.78
11/12/197311/14/1973$0.0130%1.37%$3.78
08/13/197308/15/1973$0.0130%1.37%$3.78
05/14/197305/16/1973$0.0120%1.25%$3.78
02/09/197302/14/1973$0.0120%1.25%$3.78
11/13/197211/15/1972$0.0110%1.2%$3.78
08/07/197208/09/1972$0.0110%1.2%$3.78

Projected Future Returns & Dividends for LLY

Based on past 10-year performance, here are LLY growth metrics:

Share price CAGR of +31.05%
Dividend CAGR of +12.99%

Using LLY CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, is modelled to grow as follows:

LLY (DRIP)LLY - No DRIP
Current Price$1,148.20$1,148.20
Start Shares8.718.71
Start Value$10,000$10,000
  
After 10 years:
Final Share Count9.258.71
Dividends Payment$4.49$4.49
Annual Dividends$166$156
Yield on cost1.66%1.56%
Share Price$2,978.14$2,978.14
Total Dividends$994$961
Final Value$27,547$26,898

Estimated Future Value + Dividends - LLY

NOTE: Above numbers are our estimate based on LLY's Dividend and Price CAGR over past 10 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Save 25% with annual plan (3 Months Free)
Pro
$171 ($14.25/mo) $128.25/yr ($10.69/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Stock Fundamentals
  • DCF valuation modeling
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
Start Free Trial
You save $99.75 (44%)
Most Popular
Premium
$288 ($24/mo) $216/yr ($18/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • Stocks Dashboard
Start Free Trial
You save $168 (44%)
Ultra
$576 ($48/mo) $432/yr ($36/mo)
7-day free trial
  • Everything in Premium
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Start Free Trial
You save $336 (44%)

Company Info

Eli Lilly and Company (LLY) had its IPO on 1972-06-01, and is trader on NYSE stock exchange.

Eli Lilly and Company is a prominent global pharmaceutical firm dedicated to the research, development, and commercialization of human medicines across the world. Its therapeutic offerings include a comprehensive suite of diabetes medications. This encompasses various insulin formulations like Basaglar, the Humalog family (e.g., Mix 75/25, U-100, U-200, Mix 50/50), insulin lispro products (including protamine and mix 75/25), and the Humulin line (e.g., 70/30, N, R, U-500). Furthermore, Eli Lilly provides specialized treatments for type 2 diabetes, such as Jardiance, Trajenta, and Trulicity. In oncology, Eli Lilly offers a robust portfolio targeting various cancers. These include Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza, indicated for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal and various head and neck cancers; Retevmo, used in metastatic NSCLC, medullary thyroid, and other thyroid cancers; Tyvyt for relapsed or refractory classic Hodgkin's lymphoma and non-squamous NSCLC; and Verzenio, prescribed for HR+, HER2- metastatic breast cancer, node-positive, and early breast cancer. For autoimmune and inflammatory conditions, the company markets Olumiant for rheumatoid arthritis, and Taltz, which addresses plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondyloarthritis. Addressing neurological and pain management needs, Eli Lilly provides Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain. Emgality is available for migraine prevention and episodic cluster headaches, while Zyprexa treats schizophrenia, bipolar I disorder, and aids in bipolar maintenance. Other significant products include Bamlanivimab and etesevimab, along with Bebtelovimab, both developed for COVID-19. Cialis is offered for erectile dysfunction and benign prostatic hyperplasia, and Forteo is available for osteoporosis. Eli Lilly actively engages in strategic collaborations with numerous partners, including Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; Regor Therapeutics Group; Lycia Therapeutics, Inc.; Kumquat Biosciences Inc.; Entos Pharmaceuticals Inc.; and Foghorn Therapeutics Inc. Established in 1876, Eli Lilly and Company maintains its corporate headquarters in Indianapolis, Indiana.

LLY website: https://www.lilly.com


Get Full Access to All Reports with DRIPCalc PRO

Save 25% with annual plan (3 Months Free)
Pro
$171 ($14.25/mo) $128.25/yr ($10.69/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Stock Fundamentals
  • DCF valuation modeling
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
Start Free Trial
You save $99.75 (44%)
Most Popular
Premium
$288 ($24/mo) $216/yr ($18/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • Stocks Dashboard
Start Free Trial
You save $168 (44%)
Ultra
$576 ($48/mo) $432/yr ($36/mo)
7-day free trial
  • Everything in Premium
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Start Free Trial
You save $336 (44%)